Clinical Trial Detail

NCT ID NCT02540291
Title Study of E7046 in Subjects With Selected Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements no
Sponsors Eisai Inc.
Indications

pancreatic adenocarcinoma

cervical cancer

hepatocellular carcinoma

bladder urothelial carcinoma

ovarian serous carcinoma

colorectal cancer

triple-receptor negative breast cancer

clear cell renal cell carcinoma

lung non-small cell carcinoma

head and neck squamous cell carcinoma

Therapies

E7046

Age Groups: adult senior

No variant requirements are available.